Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-17

Clinical Trial Update: Monitoring Hyperkalemia Using Point-of-care AI-enabled ECG Device Among Patients With Chronic Kidney Disease Stages 3b-5 [NA]

View source ↗

Summary

This clinical trial update describes monitoring hyperkalemia in chronic kidney disease patients (stages 3b-5) using a point-of-care AI-enabled ECG device; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Peking University First Hospital | Conditions: Chronic Kidney Disease (Stages 3b-5) | NA | Status: RECRUITING